Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.07
-0.20 (-3.19%)
May 6, 2025, 4:00 PM EDT - Market closed
Novavax (NVAX) Revenue by Segment
History
| Date | Product | Licensing Royalties and Other | Grants |
|---|---|---|---|
| Dec 31, 2024 | 190.44M | 492.41M | - |
| Sep 30, 2024 | 391.89M | 455.36M | - |
| Jun 30, 2024 | 355.91M | 428.89M | - |
| Mar 31, 2024 | 621.17M | 35.50M | - |
| Dec 31, 2023 | 531.39M | 24.99M | 427.32M |
| Sep 30, 2023 | 567.72M | 23.09M | 458.95M |
| Jun 30, 2023 | 1.19B | 5.47M | 400.30M |
| Mar 31, 2023 | 961.88M | 25.98M | 371.00M |
| Dec 31, 2022 | 1.55B | 43.99M | 382.92M |
| Sep 30, 2022 | 1.27B | 171.16M | 408.34M |
| Jun 30, 2022 | 641.08M | 212.78M | 437.08M |
| Mar 31, 2022 | 585.63M | 215.61M | 601.79M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.